non-viral crispr knock-in anti-b7-h3 car-t cells for the treatment of small cell lung cancer
Published 2 weeks ago • 32 plays • Length 27:51Download video MP4
Download video MP3
Similar videos
-
2:02
using crispr and non-viral dna in t cell engineering
-
52:47
precise and efficient non-viral crispr gene editing solutions for t cell engineering
-
57:19
a cgmp compatible, non-viral car t cell manufacturing process
-
3:57
targeting t-cell malignancies with crispr/cas9 gene edited universal car-t
-
59:01
gene targeted therapy for non small cell lung cancer
-
2:09
biomarker guidelines for non-small cell lung cancer
-
41:06
cutting edge viral and non-viral delivery platforms for t-cell engineering
-
1:33
tracking non-small cell lung cancer evolution through therapy (rx) (tracerx)
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
4:31
emerging applications of liquid biopsy in non-small-cell lung cancer
-
57:04
flexible, clinically adaptable, non-viral approaches to car tcr methodologies
-
3:33
targeting tumor cells through non-viral sleeping beauty transposon engineered cd19-car-nk cells
-
4:30
pet-boost study in nsclc
-
![non-viral t cell engineering for clinical manufacturing [webinar]](https://i.ytimg.com/vi/DO1X0-WtOqU/mqdefault.jpg)
57:57
non-viral t cell engineering for clinical manufacturing [webinar]
-
0:16
natural killer cells & car t cell therapy | immunotherapy animation
-
3:02
osimertinib for treating non-small cell lung cancer
-
3:24
car-t and car-nk cell therapy development
-
5:51
alta-1l: brigatinib vs crizotinib for alk advanced non small cell lung cancer patients
-
39:35
an instrument-free crispr-based face mask sensor for covid-19